Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
98-113
Author(s):
Vitaly Vasilevko and Elizabeth Head
Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
114-127
Author(s):
Terrence Town
Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
128-143
Author(s):
Anahit Ghochikyan
Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
144-159
Author(s):
Rawan Tarawneh and David M. Holtzman
AD Vaccines: Conclusions and Future Directions
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
160-166
Author(s):
Thomas Wisniewski
Treatment of Viral Encephalitis
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
9
Page:
56-62
Author(s):
Renan Barros Domingues
Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
1-6
Author(s):
Michael G. Agadjanyan and David H. Cribbs
The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
7-15
Author(s):
Dave Morgan
Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
16-30
Author(s):
R. Deane, R. D. Bell, A. Sagare and B. V. Zlokovic
Quantitative and Mechanistic Studies of Aβ Immunotherapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
31-49
Author(s):
Todd E. Golde, Pritam Das and Yona Levites